Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease

Patients with lung disease caused by Mycobacterium abscessus subsp. abscessus (here M. abscessus) typically have poor treatment outcomes. Although clofazimine (CFZ) has been increasingly used in the treatment of M. abscessus lung disease in clinical practice, there are no reported data on its effect...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Yang, Bumhee, Jhun, Byung Woo, Moon, Seong Mi, Lee, Hyun, Park, Hye Yun, Jeon, Kyeongman, Kim, Dae Hun, Kim, Su-Young, Shin, Sung Jae, Daley, Charles L., Koh, Won-Jung
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444135/
https://ncbi.nlm.nih.gov/pubmed/28348153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02052-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars